Rchr
J-GLOBAL ID：202001015727829729
Update date: Mar. 09, 2026
Nishimura Norihisa
ニシムラ ノリヒサ | Nishimura Norihisa
Affiliation and department：
Research field (1)：
Gastroenterology
Research keywords (3)：
肝癌
, NASH
, 肝硬変
Research theme for competitive and other funds (5)：
- 2024 - 2026 Pathophysiological analysis and therapeutic development based on vWF-ADAMTS13 regulation for poor prognostic factors in liver cirrhosis
- 2021 - 2024 加齢による肝線維化進展促進に関わる新たな因子の同定とその分子学的メカニズム
- 2021 - 2023 Development research of novel pathophysiology and therapy for hepatorenal syndrome in cirrhosis-Thrombotic microangiopathy and recombinant ADAMTS13 therapy-
- 2015 - 2018 Identification of novel treatment and biomarkers based on pharmacokinetics in patients with hepatocellular carcinoma
- 2014 - 2017 Establishment of new treatment targeting lifestyle diseases and coagulation fibrinolytic system related to the development of NASH
Papers (222)：
-
Aritoshi Koizumi, Tadashi Namisaki, Akihiko Shibamoto, Takashi Inoue, Shohei Asada, Takuya Matsuda, Satoshi Iwai, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, et al. Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response. Current Issues in Molecular Biology. 2026. 48. 2. 222-222
-
Masayoshi Takami, Tadashi Namisaki, Akihiko Shibamoto, Hiroyuki Masuda, Satoshi Iwai, Shohei Asada, Yuki Tsuji, Yukihisa Fujinaga, Shinya Sato, Norihisa Nishimura, et al. The 7S Domain of Type IV Collagen as a Noninvasive Surrogate of Portal Hypertension. Hepatology research : the official journal of the Japan Society of Hepatology. 2026
-
Yukihisa Fujinaga, Hitoshi Mori, Masayoshi Takami, Hiroyuki Masuda, Jun-ichi Hanatani, Satoshi Iwai, Shohei Asada, Akihiko Shibamoto, Yuki Tsuji, Koh Kitagawa, et al. Third-Generation Narrow-Band Imaging Versus White-Light Imaging for the Detection of Early Gastric Cancer: A Randomized Controlled Study. DEN Open. 2026. 6. 1
-
Jun-Ichi Hanatani, Norihisa Nishimura, Natsumi Shibasaki, Kazuki Shioya, Yusuke Komeda, Masayoshi Takami, Yukihisa Fujinaga, Koh Kitagawa, Shinya Sato, Kosuke Kaji, et al. Successful Conservative Management of a Traumatic Intramural Duodenal Hematoma Using a Double Elementary Diet Tube: A Case Report. Internal medicine (Tokyo, Japan). 2026
-
Jun-ichi Hanatani, Norihisa Nishimura, Natsumi Shibasaki, Kazuki Shioya, Yusuke Komeda, Masayoshi Takami, Yukihisa Fujinaga, Koh Kitagawa, Shinya Sato, Kosuke Kaji, et al. Successful Conservative Management of a Traumatic Intramural Duodenal Hematoma Using a Double Elementary Diet Tube: A Case Report. Internal Medicine. 2026
ｍore...
MISC (80)：
-
Norihisa Nishimura, Kosuke Kaji, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji. TOFOGLIFLOZIN AMELIORATES PORTAL HYPERTENSION ALONG WITH LIVER FIBROSIS PROGRESSION BY INHIBITION OF SINUSOIDAL CAPILLARIZATION IN RATS WITH LIVER CIRRHOSIS. HEPATOLOGY. 2024. 80. S1625-S1625
-
Kosuke Kaji, Norihisa Nishimura, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji. GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST, SEMAGLUTIDE PREVENTS LIVER CIRRHOSIS-INDUCED SKELETAL MUSCLE ATROPHY IN DIABETIC MICE. HEPATOLOGY. 2024. 80. S1603-S1604
-
Shinya Sato, Hiroaki Takaya, Norihisa Nishimura, Kosuke Kaji, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. DIABETES IS A RISK FACTOR FOR SARCOPENIA OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS-DRIVEN CIRRHOSIS. HEPATOLOGY. 2024. 80. S451-S452
-
Tadashi Namisaki, Shinya Sato, Kosuke Kaji, Norihisa Nishimura, Hitoshi Yoshiji. PROGNOSTIC SIGNIFICANCE OF SKELETAL MUSCLE MASS IN PATIENTS WITH ALCOHOLIC CIRRHOSIS. HEPATOLOGY. 2024. 80. S1110-S1110
-
Tadashi Namisaki, Yukihisa Fujinaga, Shinya Sato, Norihisa Nishimura, Kosuke Kaji, Hitoshi Yoshiji. HISTOLOGICAL STAGE AS PREDICTOR OF THE COMPLICATIONS OF PRIMARY BILIARY CHOLANGITIS. HEPATOLOGY. 2024. 80. S1761-S1762
ｍore...
Work history (3)：
- 2020/04 - 現在 Nara Medical University
- 2017/06 - 2020/03 NIH
- 2013/04 - 2017/03 奈良県立医科大学消化器・代謝内科 大学院生
Return to Previous Page
